| | | | | Britain on Monday demanded that the European Union allow the delivery of COVID-19 vaccines it has ordered as tensions over a possible ban on EU-manufactured shots mounted, but Brussels said drugmaker AstraZeneca was to blame. | | |
| | | A South African business lobby group called on Monday for the government to shift the emphasis on its vaccine programme to target the elderly and vulnerable sooner, to prevent hospitals being overrun in a third wave of COVID-19 infections. | | |
| | | A private company in Pakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the company's local partner told Reuters on Monday. | | |
| | | India reported its most COVID-19 cases and deaths in months on Monday, on the first anniversary of the start of a chaotic nationwide lockdown that left many people jobless and shrank the economy. | | |
| | | AstraZeneca's COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in Chile, Peru and the United States, the company said on Monday, paving the way for it to apply for U.S. approval. | | |
| | | The European Union has not formally blocked the shipment of Astrazeneca vaccines from a Netherlands factory to the UK because no export request has been made but such a request would not be approved, an EU official said. | | |
| | | Here's what you need to know about the coronavirus right now: | | |
| | | Two of China's regulators plan to bring the rules governing the sale of e-cigarettes and other new tobacco products in line with those for ordinary cigarettes. | | |
| | | AstraZeneca’s coronavirus vaccine received a major boost on Monday after data from a large trial showed it was safe and effective, potentially paving the way for its emergency authorisation in the United States as countries in Asia accelerated its rollout. | | |
| | | The Philippines on Monday reported a record daily rise of 8,019 COVID-19 infections, as authorities implemented tighter curbs in the congested capital region and hospital capacity neared critical levels in some areas. | | |
| | | Japan's KM Biologics Co said on Monday it had started a human trial for its COVID-19 vaccine, becoming the country's third candidate to advance to clinical trials. | | |
|
| |
